The ODPRN has been publishing peer-reviewed journal articles and preparing public reports since 2008. The ODPRN also completed a total of 12 drug class reviews.
- Journal articles span multiple topics, and are typically freely accessible (i.e. open-access)
- Research reports are prepared in response to research requests from the Ontario Public Drug Programs (OPDP) or are based on findings from ODPRN research. Although most reports remain confidential until the findings are prepared for peer-reviewed publication, some studies conducted by the ODPRN touch on current issues that require the rapid release of research information. These reports on high impact issues are released publicly to facilitate wider access to study findings.
- Drug class reviews were based on an innovative framework that resulted in research findings synthesized to make recommendations to the OPDP regarding public drug reimbursement policies.
Publications and reports are listed below in chronological order.
You can also sort publications by type, clinical topic and research topic using the filter button next to the column header.
|Publication Type||Date Released||Clinical Topic||Research Topic|
|wdt_ID||Title||Publication Type||Date Released||Clinical Topic||Research Topic||Additional Resources|
|1||The characteristics of treated pulmonary arterial hypertension patients in Ontario||Journal Article||01 Jan 2016||Cardiovascular Health||Descriptive and Utilization|
|2||Persistence with therapy among patients treated with warfarin for atrial fibrillation||Journal Article||26 Nov 2012||Cardiovascular Health||Drug Adherence|
|3||Low molecular weight heparin||Drug Class Review||01 May 2016||Cardiovascular Health||Drug Policy and Evaluation||Research Summary|
|4||The influence of socioeconomic status on selection of anticoagulation for atrial fibrillation||Journal Article||25 Feb 2016||Cardiovascular Health||Drug Policy and Evaluation|
|5||Impact of the JUPITER trial on statin prescribing for primary prevention||Journal Article||12 Aug 2013||Cardiovascular Health||Drug Policy and Evaluation|
|6||Trends in the coprescription of proton pump inhibitors with clopidogrel: An ecological analysis||Journal Article||26 Nov 2015||Cardiovascular Health||Drug Policy and Evaluation|
|7||Selective serotonin reuptake inhibitors and pulmonary arterial hypertension: A case-control study||Journal Article||01 Feb 2012||Cardiovascular Health||Drug Safety and Effectiveness|
|8||Rates of hemorrhage during warfarin therapy for atrial fibrillation||Journal Article||26 Nov 2012||Cardiovascular Health||Drug Safety and Effectiveness|
|9||Risk of incident diabetes among patients treated with statins: Population based study||Journal Article||23 May 2013||Cardiovascular Health||Drug Safety and Effectiveness||Research Minute|
|10||Statins and the risk of herpes zoster: A population-based cohort study||Journal Article||13 Nov 2013||Cardiovascular Health||Drug Safety and Effectiveness|